Steven Melton (born 6 January 1962) is CEO of Exemplar Healthcare,[1] former Managing Director of MyDentist,[2] and the former Chief Executive of Circle Health Ltd, the first private company to take over an NHS Hospital, namely Hinchingbrooke Hospital.[3][4][5][6]

Biography

Melton was born in Turkey on 6 January 1962 and educated at Bedford Modern School and the University of Cambridge.[3]

Melton began his working life in the personal care division of Unilever.[3] After 11 years he moved to Asda where he worked alongside Archie Norman at a critical juncture in the life of that company.[3] Melton’s peers at Asda included Justin King, Mike Coupe and Richard Baker.[3]

Melton joined Circle Health Ltd in 2008 and became CEO after the departure of Ali Parsa.[3][7] Being CEO of a private owner of a former NHS Hospital is arguably not without controversy and in an interview with The Sunday Times on 15 February 2015 Melton stated that his ‘job isn’t to be a ‘larger-than-life character. I’m not very fond of the media exposure I have had; it’s not my natural character’.[3]

References

  1. "Steve Melton". www.exemplarhc.com.
  2. "2017-10-16 - New senior appointments at IDH Group". www.mydentist.co.uk. Retrieved 8 December 2019.
  3. 1 2 3 4 5 6 7 "Money not politics drove us out of the NHS, says Circle chief – The Sunday Times". thesundaytimes.co.uk. p. 6. Archived from the original on 20 March 2015.
  4. "Steve Melton faces PAC: Circle Holdings boss in Hinchingbrooke Hospital row is next in line for Margaret Hodge treatment". The Independent. 2 February 2015. Archived from the original on 25 May 2022.
  5. Steve Melton, Circle chief executive. "HINCHINGBROOKE: Circle chief executive Steve Melton's full statement as private firm pulls out of hospital". Hunts Post.
  6. "Circle does not have a 'sustainable future with Hinchingbrooke'". ITV News.
  7. Sean Farrell (9 January 2015). "Circle says it's driven by its patients – but it's been looking rather sick itself". the Guardian.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.